Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dimension reduction, cell clustering, and cell-cell communication inference for single-cell transcriptomics with DcjComm. | Genome Biol | 2024 | 39252099 | PubTator, text mining | PubMed |
| Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation. | J Am Chem Soc | 2024 | 39226482 | PubTator, text mining | PubMed |
| An Aptamer Glue Enables Hyperefficient Targeted Membrane Protein Degradation. | JACS Au | 2024 | 39211579 | PubTator, text mining | PubMed |
| Aptamer-Loop DNA Nanoflower Recognition and Multicolor Fluorescent Carbon Quantum Dots Labeling System for Multitarget Living Cell Imaging. | ACS Appl Mater Interfaces | 2024 | 39161311 | PubTator, text mining | PubMed |
| Intraglandular dissemination: a special pathological feature. | Front Oncol | 2024 | 39135992 | PubTator, text mining | PubMed |
| Structure-based investigation of a DNA aptamer targeting PTK7 reveals an intricate 3D fold guiding functional optimization. | Proc Natl Acad Sci U S A | 2024 | 38985770 | PubTator, text mining | PubMed |
| Identification of the Binding Site between Aptamer sgc8c and PTK7. | Anal Chem | 2024 | 38889444 | PubTator, text mining | PubMed |
| Expanding the horizons of targeted protein degradation: A non-small molecule perspective. | Acta Pharm Sin B | 2024 | 38828146 | PubTator, text mining | PubMed |
| Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer. | Oncogene | 2024 | 38773263 | PubTator, text mining | PubMed |
| FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development. | Cell Death Dis | 2024 | 38740744 | PubTator, text mining | PubMed |
| Elucidating the Functional Mechanism of PTK7 in Cancer Development through Spatial Assembly Analysis Using Super Resolution Imaging. | Anal Chem | 2024 | 38708542 | PubTator, text mining | PubMed |
| Polyfluoroalkyl Tag Decoration Enables Significantly Enhanced Tumor Penetration Ability of a PTK7 Targeting Aptamer. | Bioconjug Chem | 2024 | 38695582 | PubTator, text mining | PubMed |
| Single-cell SERS imaging of dual cell membrane receptors expression influenced by extracellular matrix stiffness. | J Colloid Interface Sci | 2024 | 38678888 | PubTator, text mining | PubMed |
| Inhibitors to degraders: Changing paradigm in drug discovery. | iScience | 2024 | 38646175 | PubTator, text mining | PubMed |
| Intelligent Biogenic Missile for Two-Photon Fluorescence Imaging-Guided Combined Photodynamic Therapy and Chemotherapy in Tumors. | Anal Chem | 2024 | 38642044 | PubTator, text mining | PubMed |
| Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. | Blood Adv | 2024 | 38527292 | PubTator, text mining | PubMed |
| The Wnt Co-Receptor PTK7/Otk and Its Homolog Otk-2 in Neurogenesis and Patterning. | Cells | 2024 | 38474329 | PubTator, text mining | PubMed |
| Domain-Targeted Membrane Partitioning of Specific Proteins with DNA Nanodevices. | J Am Chem Soc | 2024 | 38466380 | PubTator, text mining | PubMed |
| Multiplex Profiling of Biomarker and Drug Uptake in Single Cells Using Microfluidic Flow Cytometry and Mass Spectrometry. | ACS Nano | 2024 | 38359901 | PubTator, text mining | PubMed |
| Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets. | JTO Clin Res Rep | 2024 | 38357092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=6